AstraZeneca has appointed a new head of its China business, after her predecessor Leon Wang was detained by authorities in the country as part of a crackdown on the healthcare sector.
Iskra Reic will take over from Wang to lead the drugmaker’s business in the country and will be based at the company’s research and development centre in Shanghai, the company said on Wednesday.
The UK-listed group added that Wang was on “extended leave” while under investigation in China.
您已閱讀20%（475字），剩余80%（1899字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。